Works by PALMER, JERRY P.

Results: 126
    1
    2
    3
    4

    Time to Peak Glucose and Peak C-Peptide During the Progression to Type 1 Diabetes in the Diabetes Prevention Trial and TrialNet Cohorts.

    Published in:
    2021
    By:
    • Voss, Michael G.;
    • Cuthbertson, David D.;
    • Cleves, Mario M.;
    • Ping Xu;
    • Evans-Molina, Carmella;
    • Palmer, Jerry P.;
    • Redondo, Maria J.;
    • Steck, Andrea K.;
    • Lundgren, Markus;
    • Larsson, Helena;
    • Moore, Wayne V.;
    • Atkinson, Mark A.;
    • Sosenko, Jay M.;
    • Ismail, Heba M.;
    • Xu, Ping;
    • DPT-1 and TrialNet Study Groups;
    • DPT-1 and TrialNet Study Groups Investigators:
    Publication type:
    journal article
    5

    Obstructive Sleep Apnea, Glucose Tolerance, and β-Cell Function in Adults With Prediabetes or Untreated Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study.

    Published in:
    2021
    By:
    • Mokhlesi, Babak;
    • Tjaden, Ashley H.;
    • Temple, Karla A.;
    • Edelstein, Sharon L.;
    • Sam, Susan;
    • Nadeau, Kristen J.;
    • Hannon, Tamara S.;
    • Manchanda, Shalini;
    • Mather, Kieren J.;
    • Kahn, Steven E.;
    • Ehrmann, David A.;
    • Van Cauter, Eve;
    • Atkinson, Karen M.;
    • Barengolts, Elena;
    • Utzschneider, Kristina M.;
    • Rue, Abby;
    • Miller, M. Annette;
    • Palmer, Jerry P.;
    • Gebremedhin, Tsige;
    • Kernan-Schloss, Abigail
    Publication type:
    journal article
    6

    OGTT Glucose Response Curves, Insulin Sensitivity, and β-Cell Function in RISE: Comparison Between Youth and Adults at Randomization and in Response to Interventions to Preserve β-Cell Function.

    Published in:
    2021
    By:
    • Arslanian, Silva A.;
    • El ghormli, Laure;
    • Kim, Joon Young;
    • Tjaden, Ashley H.;
    • Barengolts, Elena;
    • Caprio, Sonia;
    • Hannon, Tamara S.;
    • Mather, Kieren J.;
    • Nadeau, Kristen J.;
    • Utzschneider, Kristina M.;
    • Kahn, Steven E.;
    • Ehrmann, David A.;
    • Temple, Karla A.;
    • Rue, Abby;
    • Mokhlesi, Babak;
    • Van Cauter, Eve;
    • Sam, Susan;
    • Miller, M. Annette;
    • Atkinson, Karen M.;
    • Palmer, Jerry P.
    Publication type:
    journal article
    7
    8
    9
    10

    Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.

    Published in:
    2018
    By:
    • Sosenko, Jay M;
    • Skyler, Jay S;
    • Mahon, Jeffrey;
    • Krischer, Jeffrey P;
    • Beam, Craig A;
    • Boulware, David C;
    • Greenbaum, Carla J;
    • Rafkin, Lisa E;
    • Cowie, Catherine;
    • Cuthbertson, David;
    • Palmer, Jerry P;
    • and the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups;
    • Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
    Publication type:
    Correction Notice
    11
    12
    13
    14
    15
    16

    GAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study.

    Published in:
    Journal of the Endocrine Society, 2024, v. 8, n. 3, p. 1, doi. 10.1210/jendso/bvad179
    By:
    • Hampe, Christiane S;
    • Shojaie, Ali;
    • Brooks-Worrell, Barbara;
    • Dibay, Sepideh;
    • Utzschneider, Kristina;
    • Kahn, Steven E;
    • Larkin, Mary E;
    • Johnson, Mary L;
    • Younes, Naji;
    • Rasouli, Neda;
    • Desouza, Cyrus;
    • Cohen, Robert M;
    • Park, Jean Y;
    • Florez, Hermes J;
    • Valencia, Willy Marcos;
    • Stempel, Robert;
    • Palmer, Jerry P;
    • Balasubramanyam, Ashok
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23

    A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.

    Published in:
    2011
    By:
    • Sosenko JM;
    • Skyler JS;
    • Palmer JP;
    • Krischer JP;
    • Cuthbertson D;
    • Yu L;
    • Schatz DA;
    • Orban T;
    • Eisenbarth G;
    • Diabetes Prevention Trial-Type 1 and Type 1 Diabetes TrialNet Study Groups;
    • Sosenko, Jay M;
    • Skyler, Jay S;
    • Palmer, Jerry P;
    • Krischer, Jeffrey P;
    • Cuthbertson, David;
    • Yu, Liping;
    • Schatz, Desmond A;
    • Orban, Tihamer;
    • Eisenbarth, George;
    • Diabetes Prevention Trial–Type 1 and Type 1 Diabetes TrialNet Study Groups
    Publication type:
    journal article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

    Published in:
    2007
    By:
    • Sosenko JM;
    • Palmer JP;
    • Greenbaum CJ;
    • Mahon J;
    • Cowie C;
    • Krischer JP;
    • Chase HP;
    • White NH;
    • Buckingham B;
    • Herold KC;
    • Cuthbertson D;
    • Skyler JS;
    • Sosenko, Jay M;
    • Palmer, Jerry P;
    • Greenbaum, Carla J;
    • Mahon, Jeffrey;
    • Cowie, Catherine;
    • Krischer, Jeffrey P;
    • Chase, H Peter;
    • White, Neil H
    Publication type:
    journal article
    36
    37
    38
    39
    40
    41

    What's in a Name.

    Published in:
    Diabetes Care, 2003, v. 26, n. 2, p. 536, doi. 10.2337/diacare.26.2.536
    By:
    • Palmer, Jerry P.;
    • Hirsch, Irl B.
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50